MicroPort MedBot

MicroPort MedBot develops robot-assisted systems for laparoscopic, orthopaedic, vascular-interventional and other surgical procedures. Its commercial portfolio includes the multi-arm Toumai platform with telesurgery capability and the CT-planned SkyWalker joint-replacement system; Toumai passed 200 global commercial orders in February 2026.

Facts

Segment: Surgical
Country: CN
Founded: 2015
Ticker: 2252
Website: https://www.medbotsurgical.com/en/

About

About MicroPort MedBot

MicroPort MedBot develops surgical robotics across minimally invasive, orthopaedic and vascular-interventional procedures. Its portfolio includes the Toumai laparoscopic platform and SkyWalker orthopaedic system, supported by instruments, planning software and clinical-service infrastructure.

The company is part of the wider MicroPort medical-device group and markets systems across multiple countries. Procedure indications, approvals and availability differ by product and jurisdiction; product-level profiles carry those regulatory qualifications.

Products

SkyWalker - SkyWalker
Toumai - Toumai

View products

1 commercial event; 1 commercial order; latest event 2026-02-13

2026-02-13 - Commercial order - Toumai surpasses 200 global commercial orders - source: medbotsurgical.com

View

Market context

Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.

Stereotaxis - comparable profile - peer: Surgical Robotics Companies
PROCEPT BioRobotics - comparable profile - peer: Surgical Robotics Companies
Microbot Medical - comparable profile - peer: Surgical Robotics Companies

View market context

Timeline

2026-07-22 - Market Signal - MicroPort MedBot forecasts first half-year profit as Toumai overseas revenue grows - The company forecast first-half profit of roughly RMB28 million to RMB40 million versus a RMB115 million loss a year earlier. Expected revenue growth was approximately 200% to 230% year over year. MicroPort MedBot cited overseas Toumai surgical-robot revenue… - source: hkexnews.hk
2026-03-06 - Deployment - Toumai supports 2,400 km UK-Gibraltar telesurgery - The 6 March procedure was the first remote robotic surgery operated from the United Kingdom. A high-speed fiber connection with 5G backup delivered 30 millisecond one-way latency between London and Gibraltar. A complete surgical team remained beside the… - source: medbotsurgical.com
2026-02-13 - Commercial Order - Toumai surpasses 200 global commercial orders - Toumai doubled from more than 100 orders in October 2025 to more than 200 by February 2026. Twelve markets had placed more than five orders each, including 14 cumulative orders in India and more than 10 in Brazil. The platform had supported nearly 800 remote… - source: medbotsurgical.com

View timeline

Team

Chao He - Executive Director and President - Oversees group R&D, day-to-day management and strategic development.
Yu Liu - Chief Commercial Officer and Executive Vice President - Leads commercialization and clinical-market development across MicroPort MedBot's surgical-robot portfolio.

View team

Relations

MicroPort Scientific Corporation - Controlling Shareholder - MicroPort Scientific Corporation is MicroPort MedBot's controlling shareholder.

View relations

Resources

Official filings, investor material and product documentation for MicroPort MedBot's laparoscopic, orthopaedic and telesurgery systems.

Toumai - image · MicroPort MedBot
SkyWalker - image · MicroPort MedBot
MicroPort MedBot 2025 Annual Report - PDF · Shanghai MicroPort MedBot (Group) Co., Ltd. · MicroPort MedBot

View resources